U.S. Markets open in 6 hrs 49 mins

TearLab Corporation (TLB.TO)


Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
2.87+0.21 (+7.89%)
At close: 3:53PM EDT

TearLab Corporation

9980 Huennekens Street
Suite 100
San Diego, CA 92121
United States
858-455-6006
http://www.tearlab.com

SectorHealthcare
IndustryMedical Laboratories & Research
Full Time Employees75

Key Executives

NameTitlePayExercisedAge
Mr. Elias VamvakasExec. Chairman and Sec.231.51kN/A58
Mr. Joseph S. JensenChief Exec. Officer, Pres and Director571.93kN/A45
Mr. Wes BrazellChief Financial Officer364.73kN/A51
Dr. Richard L. Lindstrom M.D.Scientific Advisor and Independent Director36kN/A69
Dr. Paul M. Karpecki OD, FAAOScientific Advisor, Independent Director and Member of Clinical Advisory Board36kN/A50
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

TearLab Corporation operates as an in-vitro diagnostic company in the United States. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The company’s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corporation was founded in 1996 and is headquartered in San Diego, California.

Corporate Governance

TearLab Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.